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Abstract
Background: Results from different trails have provided evidence of protective effects of cis-9,trans-11-conjugated
linoleic acid (CLA) on cardiovascular diseases. But the inhibition of prolyl hydroxylase 1 (PHD1) associated with
induction of hypoxia inducible factors (HIFs) by CLA in these protective effects has never been reported before.
The objective of this study was to evaluate if the two predominant cis-9,trans-11 (c9, t11), trans-10,cis-12 (t10, c12)
CLA isomers and mixture of these two isomers can inhibit PHD1 with induction of HIFs in myocardium in mice
and subsequent effects on myocardium metabolism.
Results: CLA mixture and c9, t11 CLA inhibited PHD1 protein expression and increased the levels of protein and
mRNA in HIF-2a in myocardium in mice. Meanwhile, CLA mixture and c9, t11 CLA also elevated the expression of
HIF related transcriptional factors like PDK4 and PPARa. The reprogramming of basal metabolism in myocardium in
mice was shown on increasing of GLUT4 gene expression by c9, t11 CLA supplemented group. UCP2 was
increased by CLA mixture and c9, t11 CLA for attenuating production of ROS.
Conclusion: CLA mixture and c9, t11 CLA could inhibit PHD1 and induce HIF-2a in myocardium in mice, which is
associated with upregulation of PDK4 by activation of PPARa. This process also implies a reprogramming of basal
metabolism and oxidative damage protection in myocardium in mice. All the effects shown in hearts of mice are
due to c9, t11 CLA but not t10, c12 CLA.
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Background
Heart disease like myocardial infarction (MI) or acute
myocardial infarction (AMI) and heart ischemia com-
monly are known as cardiovascular diseases (CVDs),
which are the interruption of blood supply to part of
the heart, causing heart cells to die. In 2008, an esti-
mated 17.3 million people died from CVDs in the
world, in which over 80% of CVD deaths take place in
low-and middle-income countries [1].
Oxygen availability is insufficient when inadequate
blood supply happens. Cells undergo adaptive changes
in gene expression that promote survival in low oxygen
(hypoxic) environment. Cellular adaptation to oxygen
availability is mediated by the hypoxia inducible factors
(HIFs), a member of the basic helix-loop-helix-PAS
superfamily which transactivate a host of genes in the
nucleus involved in the adaption of hypoxic stress [2].
HIF consists of an unstable a subunit and a stable b
s u b u n i tt h a tb i n d sD N Aa ts p e c i f i cl o c a t i o n st e r m e d
hypoxia response elements (HERs) to regulate many
genes expression related to hypoxia [3]. HIF-a subunit
is regulatory and unique to the hypoxic response. HIF-b
subunit is constitutive and also involved in xenobiotic
response. Three different genes encoding HIF-a subunit
are found in mammals: HIF-1a, HIF-2a and HIF-3a [2].
HIF-a proteins are maintained at low steady-state level
under normoxic condition via hydroxylation by HIF pro-
lyl hydroxylases (PHDs) [4]. Among these three HIF-a
isoforms, HIF-2a in particular shows a unique ability to
induce metabolic reprogramming, which ultimately
makes mitochondrion harmless but less active in certain
conditions by regulating expression of numerous genes
[5]. PHDs are 2-oxoglutarate dioxygenases, which are
present in three forms in mammals, designated PHD1,
PHD2 and PHD3 [6]. Hydroxylated HIF recruits the
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[7,8], which in turn tags HIF with ubiquitin groups and
targets it for degradation by proteasome [9,10].
Many cardiovascular diseases including anemia, myo-
cardial infarction and stroke are linked to inadequate
tissue oxygen. So, up-regulation of HIFs by inhibition of
PHDs may have beneficial effect on therapy for hypoxia
dependent process involved in cardiovascular disease
[10]. The availability of less cumbersome non-toxic inhi-
bitors of PHDs has been proved very useful for thera-
peutic intervention [11-13].
Conjugated linoleic acid (CLA) refers to a group of
positional and geometric isomers of the essential fatty
acid-linoleic acid (LA), which is produced by the bacter-
ial biohydrogenation of linoleic acid in the gut of rumi-
nant animals via an enzymatic isomerase reaction [14].
CLA is found naturally in food products from these ani-
mals predominantly as the cis-9,trans-11 form, whereas
synthetic CLA preparations consist of a few different
isomers with approximately equal amount of cis-9,trans-
11 and trans-10,cis-12 CLA [15].
Since be found from 1980s, many research has been
done with biological functions of these two predominant
isomers of CLA. These isomers are both biologically
active and known to have different physiological effects
[16]. The original discovery of CLA was as an anticancer
component, which was proven to be an effective preven-
tion tool in a number of animal cancer models, such as
s k i n ,c o l o n ,m a m m a r y ,l u n ga n dl i v e r[ 1 7 , 1 8 ] .B o t hi s o -
mers have proven to be effective in prevention of can-
cer, while others reported differences in anti-cancer
activities between these isomers [19,20]. t10, c12 CLA
was reported to prevent cardiovascular disease [21,22]
and reduce body fat in animals [23], which is one of the
most important activities of CLA. While c9, t11 CLA
was not responsible for these effects [24,25]. There was
also research about CLA that it can reduce inflamma-
tory and improve immune response [26-28]. But the
controversy was that t10, c12 CLA induced inflamma-
tory responses in white adipose tissue [29]. Besides posi-
tive effects induced by CLA, there were also negative
effects reported for CLA, especially t10, c12 CLA. Mice
fed with CLA mixture or t10, c12 CLA resulted in lipo-
dystrophy, hyperinsulinemia and liver steatosis, whereas,
c9, t11 CLA had no negative effect like t10,12 CLA
[30-32].
There was research reported that c9, t11 CLA in adi-
pose tissue was associated with a lower risk of MI in
basic [33]. But the mechanism of this protective effect is
still not fully defined. We estimated that CLA may have
influence on PHDs, which is related to the protective
effect on myocardium. The mice model was used by
supplementing with individual isomers of CLA and the
mixture of these two isomers in the diet to determine if
these effects are associated with role of prolyl hydroxy-
lase inhibitor on myocardium.
Material and method
Material
Semipurified diet (TD.04460) was from Harlan Teklad
(Madison, WI). Antibodies for prolyl hydroxylase 1
(PHD1) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were purchased from Bethyl (Montgomery,
TX). Antibodies for hypoxia inducible factor-2 alpha
(HIF-2a), peroxisome proliferator-activated receptor
alpha (PPARa) and secondary antibody coupled to horse
radish peroxidase (HRP) were purchased from Abcam
(Cambridge, MA). Other solvents used were purchased
from either Sigma Chemical Co. (St. Louis, MO) or
Fisher Scientific (Pittsburg, PA).
Animal and diet
Forty six-month old female ICR mice were randomized
into four groups of ten mice each. Animals were housed
in individual wire-bottomed cages in a temperature-con-
trolled, humidified room maintained on a 12 h on/off light
cycle and were provided free access to food and water.
The mice were fed a semipurified powered diet
(TD.04460) (Table 1). Diets were prepared at the begin-
ning of the study and kept at -20°C until use. Fresh diet
was provided three times a week. After 1 week adaptation,
animals were fed one of the following diets; control, 0.5%
CLA mixture (Mixture), and 0.20% cis-9,trans-11 CLA (c9,
t11 CLA), or 0.20% trans-10,cis-12 CLA (t10, c12 CLA).
0.20% of the individual isomers are equivalent to the levels
found in 0.5% CLA mixture diet. Body weight was mea-
sured weekly. All CLA preparations were purchased from
Natural ASA (Hovdebygda, Norway). The composition of
the CLA preparations is given in Table 2.
Sacrifice and tissue sample collection
After 8 weeks, animals were sacrificed by CO2 asphyxia-
tion after 4 h fasting. Hearts were removed and frozen
Table 1 TD.04460 Basal Mix (94%)
Formula g/Kg
Casein, “Vitamin-Free” Test 206.39
L-Cystine 3.192
Corn Starch 357.377
Maltodextrin 140.43
Sucrose 93.1
Soybean Oil 95.75
Cellulose 53.2
Mineral Mix, w/o Ca (04374) 37.24
Vitamin Mix, AIN-93-VX (94047) 10.64
Choline Bitartrate 2.66
TBHQ, antioxidant 0.021
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for analysis.
mRNA expression analysis
From frozen hearts, mRNA expression levels of hypoxia
inducible factor-1 alpha (HIF-1a), endothelial PAS
domain-containing protein 1 (EPAS1), aryl hydrocarbon
receptor nuclear translocator 2 (ARNT2), egl nine homo-
log 2 (EGLN2), pyruvate dehydrogenase kinase 4 (PDK4),
peroxisome proliferator-activated receptor alpha (PPARa),
carnitine palmitoyltransferase 1b (CPT1b), glucose trans-
porter type 4 (GLUT4), uncoupling protein 2 (UCP2) were
analyzed by real-time PCR using StepOnePlus™ Real-
Time PCR System with StepOne Software v2.0 (Applied
Biosystems, Foster City, CA), TaqMan
® Gene Expression
Master Mix (Applied Biosystems, Foster City, CA) and
TaqMan Gene Expression Assays (Applied Biosystems,
Foster City, CA). Total RNA from heart was isolated with
Trizol Reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Total RNA was reverse-tran-
scribed using High Capacity cDNA Reverse Transcription
kit (Applied Biosystems, Foster City, CA). The reference
sequence for the mRNAs, the housekeeping gene control
(GAPDH) is shown in Table 3.
Western blot analysis
Tissue lysates were prepared in homogenization buffer [50
mM Tris-HCl pH 7.5, 10%(v/v) glycerol, 5 mM
magnesium acetate, 0.2 mM EDTA, 0.5 mM dithiothreitol
(DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF)] and
centrifuged at 12,000 r.p.m. for 20 min at 4°C. Protein
concentration was determined by Bio-Rad protein assay
(Hercules, CA) using 1.4 mg/mL bovine serum albumin
(BSA) as the standard. Proteins (25 μg) from each sample
were separated on SDS-PAGE and transferred to PVDF
membranes (Millipore, Billerica, MA). After blocking with
a specific primary antiserum in Tris buffered saline (TBS)
containing 0.05% Tween-20 (TBS-T) and 5% non-fat dry
milk at 4°C overnight, the membrane was incubated with
each antibody (anti-PHD1, anti-HIF-2a, anti-PPARa, anti-
GAPDH) at 4°C overnight. Finally, after three washes with
TBS-T, the blots were incubated with secondary antibody
coupled to HRP for 1 h at room temperature, visualized
using ECL Plus Western Blotting Detection System (GE
Healthcare, Buckinghamshire, UK) and quantified by
Kodak Image Station Software (Scion, Frederick, MD).
Relative protein levels were determined by comparison to
GAPDH band intensity, which was used as internal con-
trol for western blotting analysis.
Statistical analysis
Data are shown as means and standard errors. All ana-
lyses were carried out using SAS software (Version 9.2,
SAS institute Inc., Cary, NC) by one-way analysis of var-
iance (ANOVA) followed by Tukey’s multiple compari-
son test.
Results
Body weight
No significant difference in body weight was observed
with the exception of week 4, where CLA mixture-fed
animal had significant lower weight compared to control
(Table 4).
Gene expressions of HIFs and PHD1
The effect of individual isomers of CLA and CLA mix-
ture on gene expressions of three types of HIF-a subu-
nits, HIF-b subunit and HIF-a subunit hydroxylase were
determined. As shown in Figure 1A, c9, t11 CLA had
effect on HIF-1a gene expression. As seen in Figure 1B,
1-fold increase in EPAS1 (HIF-2a)g e n ee x p r e s s i o nw a s
noted in mice fed with c9, t11 CLA and the same effect
was also seen in CLA mixture-fed mice (P <0 . 0 5 ) .H I F -
3a gene expression was undetermined among all treat-
ments. ARNT2 (HIF-b) and EGLN2 (PHD1) gene expres-
sions were unaltered by all treatment (Figure 1C and 1D).
Protein expressions of HIF-2a and PHD1
After determining the effect of individual isomers of
CLA and CLA mixture on HIFs and PHD1 in mRNA
level, protein expressions of HIF-2a and PHD1 from
animals were also determined. As shown in Figure 2A
Table 2 Composition (%) of CLA Preparations Used in
this study
a
CLA preparation
FA > 90% c9, t11 > 90% t10, c12 Mixture
c9, t11 CLA 88.6 5.7 44.3
t10, c12 CLA 3.0 89.5 43.9
Oleic acid (18:1) 3.7 1.6 5.5
other 3.7 3.2 6.3
aAnalytical data provided by Natural ASA (Hovdebygda, Norway)
Table 3 Information of gene primers used for RT-PCR
Gene Assay ID RefSeq Exon
Boundary
Assay
Location
ARNT2 Mm00476004_m1 12-13 1343
CPT1b Mm00487200_m1 NM_009948.2 17-18 2228
EGLN2 Mm00519067_m1 NM_053208.4 2-3 1227
EPAS1 Mm01236112_m1 NM_010137.3 6-7 1192
GLUT4 Mm00436615_m1 NM_009204.2 9-10 1328
HIF-1a Mm00468869_m1 NM_010431.2 4-5 879
HIF-3a Mm00469373_m1 10-11 1407
PDK4 Mm01166879_m1 NM_013743.2 3-4 454
PPARa Mm00440939_m1 NM_011144.6 7-8 1371
UCP2 Mm00627597_m1 NM_011671.4 1-2 119
GAPDH NM_008084.2
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observed in control-fed animal compared to other
groups. The effect of CLA mixture and c9, t11 CLA on
increasing HIF-2a protein expression was shown in Fig-
ure 2B and 2E.
Gene and protein expressions of PPARa pathway
As recently noted [5], enhanced expressions of PDK4 and
PPARa associated with stabilized HIF-2a were shown in
mouse skeletal muscle. To determine if the effect of indi-
vidual isomers of CLA and CLA mixture on stabilization
Table 4 Effect of individual isomers of CLA and CLA mixture on body weight in the mice
Diet BW0 BW1 BW2 BW3 BW4 BW5 BW6 BW7 BW8
Control 25.90 ± 0.65
a 29.68 ± 0.44
a 29.49 ± 0.51
a 30.19 ± 0.60
a 30.40 ± 0.64
a 30.29 ± 0.41
a 31.94 ± 0.44
a 32.93 ± 0.52
ab 33.17 ± 0.58
ab
CLA mixture 25.90 ± 0.65
a 28.58 ± 0.46
a 28.03 ± 0.58
a 28.68 ± 0.68
a 28.44 ± 0.77
b 29.29 ± 0.77
a 32.00 ± 0.73
a 32.30 ± 0.71
b 31.88 ± 0.79
b
c9, t11 CLA 25.92 ± 0.65
a 29.82 ± 0.61
a 29.41 ± 0.68
a 30.23 ± 0.62
a 29.93 ± 0.67
ab 30.04 ± 0.82
a 32.36 ± 0.69
a 34.36 ± 0.82
a 34.29 ± 0.89
a
t10,12 CLA 25.63 ± 0.63
a 29.31 ± 0.41
a 28.92 ± 0.43
a 29.79 ± 0.45
a 29.20 ± 0.32
ab 30.93 ± 0.32
a 32.82 ± 0.41
a 34.05 ± 0.44
ab 33.26 ± 0.60
ab
Body weight (BW) in grams was measured weekly (0-8 weeks). Female mice were fed one of the treatment diets for 8 weeks: control, 0.5% CLA mixture, 0.2% c9,
t11 CLA and 0.2% t10, c12 CLA. Values within a column not sharing a common superscript letter indicate significant difference at P < 0.05. Numbers are mean ±
S.E. (n = 10)
Figure 1 Effects of individual isomers of CLA and CLA mixture on gene expressions of HIFs and PHD1 from the heart: (A) HIF-1a, (B) EPAS1
(HIF-2a), (C) ARNT2 (HIF-b) and (D) EGLN2 (PHD1). Female mice were fed one of the treatment diets for 8 weeks: control, 0.5% CLA mixture, 0.2%
c9, t11 CLA and 0.2% t10, c12 CLA. Different letters in each figure indicate significant difference at P < 0.05. Numbers are mean ± S.E. (n = 5).
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and PPARa expressions in myocardium in mice were
measured. Compared with control group (P < 0.05), a sig-
nificant elevation of PDK4 gene expression was evident
in mice fed with CLA mixture and c9, t11 CLA, as shown
in Figure 3A. The same trend of PPARa gene expression
was also observed as PDK4 gene expression (P < 0.05)
(Figure 3B). Similar as PPARa gene expression, CLA
mixture, c9, t11 CLA but also 10,12 CLA increased
PPARa protein expression in comparison with control
(Figure 3C and 3D).
Gene expressions of glucose and lipid metabolism
enzymes
As a marker for glucose metabolism, GLUT4 gene
expression was only increased by c9, t11 CLA fed group
compared with the other groups (P < 0.05) (Figure 4A).
For a key enzyme of fatty acid b-oxidation, CPT1b gene
expression was not altered by all treatments (Figure 4B).
CLA mixture and c9, t11 CLA significantly increased
UCP2 gene expression (P < 0.05) relative to control and
t10, c12 CLA fed animals (Figure 4C).
Discussion
In this study, CLA mixture and the two predominant
isomers of CLA showed the ability to inhibit PHD1 pro-
tein expression. But interestingly, only CLA mixture and
c9, t11 CLA played a role in stabilizing HIF-2a in the
normoxia environment and affected expressions of HIF
related transcriptional genes with inhibition of PHD1 in
hearts of mice. This is a new discovery of well-studied
CLA on myocardium protective effect.
One of the important effects of CLA is on decreasing
body weight gain, which was proved in various animal
 
Figure 2 Effects of individual isomers of CLA and CLA mixture on protein expressions from the heart: (A) PHD1 and (B) HIF-2a;
relative band intensity statistical results: (D) PHD1 and (E) HIF-2a. (C) GAPDH was used as internal control for western blotting analysis.
Female mice were fed one of the treatment diets for 8 weeks: control, 0.5% CLA mixture, 0.2% c9, t11 CLA and 0.2% t10, c12 CLA. Different
letters in each figure indicate significant difference at P < 0.05. Numbers are mean ± S.E. (n = 3).
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ings were shown when those animals were given high
amount of CLA, in which t10, c12 CLA was contributed
to this effect [35,36]. When animals were supplemented
with low amount of CLA mixture (≤ 0.5% in the diet) or
the two predominant isomers of CLA, the body weights
were not affected [37-39], which is consistent with our
study.
Since PHD1 is a direct oxygen sensor, alternation of
expression of PHD-1 is expected to change hypoxic
adaptation [40]. Most of the PHD inhibitors reported so
far, e.g. DMOG [41], 3,4-DHB [42], FG-0041 [43] are
chemicals. None of them is from natural food like CLA
which is contained in milk or beef. Inhibition of PHD1
associated with stabilized expression HIF-2a expression
in normoxia condition was seen in CLA mixture and c9,
t11 CLA fed mice, which is consistent with a former
study that mice lacking PHD1 (PHD1-null mice) showed
significant expression of HIF-2a in the absence of
hypoxia [5].
Specifically, CLA mixture and c9, t11 CLA increased
HIF-a expression like HIF-1a and HIF-2a in mRNA or
protein level. The protective effect of HIFs within differ-
ent tissues has already been noted before [5,44,45]. How-
ever, there is a debate about the expression of HIF-a in
mRNA and in protein level. Research indicated that there
was no significant increase in the mRNA expression of
EPAS1 [46,47]. This may be due to posttranscriptional
regulation as found in specific cell types [48,49]. From
the results showing in the experiment, the regulation of
expression of EGLN2 (PHD1) in different levels may
share the same mechanism as HIF-a. Interesting, t10,
c12 CLA also down-regulated PHD1 protein expression,
but it was not as potent as 19, t11 CLA on EPAS1 expres-
sion, which may be the difference of bioactivity of these
two isomers of CLA. In general, HIF-b is constitutively
expressed and heterodimerizes with HIF-a subunit in the
nucleus to form a complex, which binds to hypoxia-
responsive elements in enhancers and promoters of oxy-
gen-responsive genes under hypoxic conditions [47].
Consistent with the former research, the expression of
ARNT2 was not altered by all treatments in this study.
The possible mechanism inducing protective effect of
HIFs, especially HIF-2a,i sl i n k e dt oa ni n c r e a s ei nt h e
expression of PDK4 [50]. In the normoxic environment,
pyruvate enters the tricarboxylic acid (TCA) cycle inside
the mitochondrion where it generates ATP in the pre-
sence of oxygen. But with the inhibition of PHD1 or in
the hypoxia environment like heart ischemia, entry of
pyruvate is restricted by expression of PDK4, which is
associated with induction of HIF-2a [5,51]. In this
study, PDK4 gene expression was upregulated in mice
fed with CLA mixture and c9, t11 CLA.
PPARa is known to activate the PDK4 gene [51].
Research on the hibernating mammal model also showed
the level of PDK4 mRNA increased greatly by activation
Figure 3 Effects of individual isomers of CLA and CLA mixture on gene and protein expressions of PPARa pathway from the heart: (A)
PDK4 gene expression, (B) PPARa gene expression, (C) protein relative band intensity statistical result of PPARa and (D) PPARa
protein expression. (E) GAPDH was used as internal control for western blotting analysis. Female mice were fed one of the treatment diets for
8 weeks: control, 0.5% CLA mixture, 0.2% c9, t11 CLA and 0.2% t10, c12 CLA. Different letters in each figure indicate significant difference at P <
0.05. Numbers are mean ± S.E. (n = 5 for gene expressions and n = 3 for protein expression).
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agonist clofibrate-treated rats had an improved recovery
of post-ischemic contractile function and reduced ische-
mia/reperfusion (I/R)-induced infarct size. The coinci-
dent upregulation of PPARa and PDK4 in PHD1-
deficient was also demonstrated by knockdown of
PPARa in muscles of PHD1-deficient mice in vivo and
feeding wild-type mice with PPARa agonist [5]. In this
study, we found that CLA mixture and the two predomi-
nant isomers of CLA significantly increased PPARa pro-
tein expression. This result, combined with PDK4 gene
expression and HIF-2a expression, suggests that PPARa
activated by CLA mixture and c9, t11 CLA, with induc-
tion of HIF-2a, can initiate PDK4 gene expression.
Induction of HIF-2a by inhibition of PHD1 implies a
reprogramming of basal metabolism in mice, especially in
energy production and utilization like glucose metabo-
lism and fatty acid metabolism. Glycolytic flux was
increased in mouse muscle fiber in low oxygen condi-
tions [5]. As a marker for glucose metabolism, c9, t11
CLA fed mice increased GLUT4 gene expression signifi-
cantly in this study. Combined, c9, t11 CLA may induce
more glucose entering cell cytoplasm to generate ATP by
glycolysis when PHD1 was inhibited. But for t10, c12
CLA, which promoted dysregulation of lipid and glucose
metabolism in hepatic tissue while c9, t11 CLA had not
effect [32]. There was also another research reported that
mice supplemented 0.5% CLA mixture showed different
Figure 4 Effects of individual isomers of CLA and CLA mixture on gene expressions of glucose and lipid metabolism enzymes from
the heart: (A) GLUT4, (B) CPT1b and (C) UCP2. Female mice were fed one of the treatment diets for 8 weeks: control, 0.5% CLA mixture, 0.2%
c9, t11 CLA and 0.2% t10, c12 CLA. Different letters in each figure indicate significant difference at P < 0.05. Numbers are mean ± S.E. (n = 5).
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muscle tissue [53]. All the evidences showed in experi-
ments suggested that the two predominant isomers of
CLA may have diverse effect on glucose metabolism in
different tissues. CPT1b is known as a rate-limiting
enzyme in fatty acid b-oxidation which transfers fatty
acids through mitochondrial membrane to be oxidized
within the mitochondrial matrix [54]. A former research
showed that fatty acid oxidation was not altered in
PHD1-deficient mice [5], which is consistent with our
research that CPT1 mRNA expression was not changed
during PHD1 inhibition by CLA mixture and the two
predominant isomers of CLA supplementation in the
diet.
As an important energy expenditure parameter, the
effect of uncoupling proteins (UCPs) has become promi-
nent in the field of thermogenesis, especially UCP1 [55].
But for UCP2 and UCP3, there is a consensus that the
primary function of UCP2 and UCP3 is to attenuate
mitochondrial production of free radical to protect
against oxidative damage, degenerative disease and aging
rather than to promote gross thermogenesis or energetic
inefficiency [56,57]. Oxidative damage caused by reactive
oxygen species (ROS) is produced in mitochondrion,
which can trigger the toxic effects living with oxygen. In
contrast, oxygen depletion (hypoxia) also increases mito-
chondrial ROS that is detrimental to cells unless attenu-
ated [58]. In this study, the UCP2 gene expression in
mice fed with CLA mixture and c9, t11 CLA was ele-
vated greatly, which is consistent with former research
done on effect of elucidating UCP2 on attenuating ROS
production [59,60].
Conclusion
To our knowledge, this study is the first to examine the
effect of CLA on inhibition of PHD1 in vivo.O n eo ft h e
two predominant isomers of CLA- c9, t11 CLA showed
more potent effect than the other CLA isomer- t10, c12
CLA. This inhibitory effect is associated with induction of
HIF-2a. Several lines of evidence suggest the protective
effect of c9, t11 CLA on inhibition of PHD1 plays a part
by upregulation of PDK4 gene expression, which is acti-
vated by PPARa. This process can imply a reprogramming
of basal metabolism in hearts of mice by increasing glyco-
lysis. Meanwhile, c9, t11 CLA also increased UCP2 gene
expression to attenuate the damage of ROS. This study
provides a new interpretation of protective effect in myo-
cardium in vivo by CLA, especially one of the predominant
isomers-c9, t11 CLA.
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